BioMedReports avatar

BioMedReports

BioMed Reports
Los Angeles, CA

Joined Sep 17, 2010

http://www.biomedreports.com

BioMedReports.com is the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors.

  1. BioMedReports
    Don't let those shorts have your shares! $RPC up 39% and climbing!
  2. BioMedReports
    Don't let those shorts have your shares! $RPC up 39% and climbing!
  3. BioMedReports
    Don't let those shorts have your shares! $RPC up 39% and climbing!
  4. BioMedReports
    Don't let those shorts have your shares! $RPC up 39% and climbing!
  5. BioMedReports
    $RPC up 22% and climbing. Big cover buys coming in as we head into the close today. Looking for 3pm to be the golden hour.
  6. BioMedReports
    $RPC up another 11% today and going higher. Watch closely what will happen at 3pm! http://stk.ly/f2zpPP
  7. BioMedReports
    Is $CVM about to announce a long awaited key development? Subscribers Only Report: http://stk.ly/dGtNBi
  8. BioMedReports
    The perfect storm continues to brew at $RPC. Shares up again and headed higher into 3 day break! http://stk.ly/f2zpPP
  9. BioMedReports
    $ACTC profit taking likely done for now. 14-3 Day Raw Stochastic support level at $.22. Nice day trade at these levels.http://stk.ly/hBRaJ4
  10. BioMedReports
    $RPC out ahead of the pack again. Stock keeps seeing higher highs in the last few days with no sign of slowing down...http://stk.ly/flkmoQ
  11. BioMedReports
    $XOMA just going crazy.
  12. BioMedReports
    $RXII starting to bounce back after sell off. Up 6% and climbing after sources tell us that pharma partnership could close early Q1 2011.
  13. BioMedReports
    $ACTC up another 8% on 24 million shares traded thus far. As we predicted at $.14, the stock would re-test previous $.26 level highs.
  14. BioMedReports
    $RPC shares up 20% in early trading. More to come...http://stk.ly/f7M3D9
  15. BioMedReports
    $RPC up 40% on rumor that AMEX will approve the company's massive debt to equity swap. Also major validation coming from Mayo Clininc.

    Follow BioMedReports on StockTwits!

    Follow investors and traders that match your style and get a personalized stream of news, charts, and ideas.

    Trader Profile

    More